Preview Mode Links will not work in preview mode

CorConsult Rx: Evidence-Based Medicine and Pharmacy

Mar 14, 2023

On this episode, we review the recently published CLEAR-outcomes trial that was looking at bempedoic acid's (Nexletol) ability to lower the risk of CV events in patients who were unable to tolerate statins at their recommended doses.

While recording this episode, we used the trial summary written by Dr. Alex Poppen, PharmD who is the author/owner of the book High-Powered Medicine: Landmark Clinical Trial Reviews. To see all of the study summaries that he has available, check out his website below:

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.